In addition to the expansion in Springdale, Ohio, the company plans to enhance its corporate headquarters in Evendale, Ohio. Both facilities, nearby one another, sit just outside of Cincinnati.
Enable Injections plans for its new 90,000-square-foot manufacturing center to support ongoing in-house manufacturing and supply of its enFuse medicine delivery technology. The company develops the enFuse platform, which allows hands-free, hidden needle drug delivery of up to 25 mL. Its simple design enables flexibility for at-home self-administration or in-clinic use.
The FDA cleared the system for the delivery of Empaveli in October. Enable Injections says it’s the first-ever hands-free wearable technology that allows patients to self-administer large-volume medications subcutaneously without an IV or syringe pump.
Get the full story at our sister site, Drug Delivery Business News.
